← Back to patent-cliff list
DC-806
Tier C — Watch / tradeDC-806
Dice Therapeutics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：IL17
Indications (approved)：Plaque psoriasis
Regional status
US
Phase II
2023-05-02
EU
Phase II
2023-05-02
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of DC-806?
Approved indications include: Plaque psoriasis.
When does the DC-806 patent expire?
No public expiry year is available for DC-806 yet; this page updates once verified.
How do I get a quote for DC-806 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21